Author Archives : Editorial Team

Home  >>  Author : Editorial Team

New member: Welcome to PAASP in our cluster

On March 15, 2018, Posted by , In News, By , With Comments Off on New member: Welcome to PAASP in our cluster

We are happy to welcome in our cluster PAASP GmbH (Partnership for Assessment and Accreditation of Scientific Practice). “Quality in Research is the basis for the development of novel drugs.” Anton Bespalov, CEO The PAASP GmbH is a full-service consulting and auditing company that specializes on providing assessment of operational…

EMBL: Chromatin usage reveals developmental trajectories

On March 15, 2018, Posted by , In Research Article, By , , With Comments Off on EMBL: Chromatin usage reveals developmental trajectories

Information (arrows) emanating out of chromatin to give rise to different cell types. IMAGE: Campbell Medical Illustration EMBL scientists show how chromatin usage in individual cells reveals developmental trajectories Both cell type and developmental stage can be deduced from measurements of chromatin accessibility in thousands of single cells, researchers at…

Sciomics: Solving Alzheimers with this company’s new approach?

On March 14, 2018, Posted by , In News, By , , With Comments Off on Sciomics: Solving Alzheimers with this company’s new approach?

Labiotech.eu media recently profiled our member Sciomics, a German Cancer Research Center (DKFZ) spin-off founded in 2013 by a team of researchers led by Dr. Christoph Schröder and Dr. Jörg Hoheisel. Sciomics has developed antibody microarrays as a tool for analyzing complex protein samples. Using their expertise, they are able to address…

University of Heidelberg – Innovation Campus: new construction site for the network “Biology at the nanoscale”

On March 13, 2018, Posted by , In News, By , , With Comments Off on University of Heidelberg – Innovation Campus: new construction site for the network “Biology at the nanoscale”

Baden-Württemberg Ministry of Science will support a research bridge between the Ruperto Carola and the Max Planck Institute for Medical Research in Heidelberg, by funding a new building in the life science innovation campus “Heidelberg 4 life”. The funding has been formalized by the Minister of Science, Research and the…

NCT Heidelberg: Combination therapy in neuroblastoma: It`s all about the mix

On March 13, 2018, Posted by , In Research Article, By , , With Comments Off on NCT Heidelberg: Combination therapy in neuroblastoma: It`s all about the mix

The combination of two cell division inhibitors causes malignant nervous system tumors to die off, as scientists from the “Hopp Children’s Cancer Center at the NCT Heidelberg” (KiTZ) have shown in experimental studies.The combination strategy could be the key to new targeted therapies against this aggressive type of tumor. The…

BioMed X and Roche announce research collaboration in the field of immunology

On March 13, 2018, Posted by , In News, By , , With Comments Off on BioMed X and Roche announce research collaboration in the field of immunology

BioMed X announced today the initiation of a new research collaboration with F. Hoffmann-La Roche Ltd in the field of immunology. Within the framework of the agreement, BioMed X will launch a global call for applications to establish a new biomedical research group in Heidelberg. The main objective of the…

Innovation wanted: Baden-Württemberg Innovation Award 2018

On March 12, 2018, Posted by , In Funding/Prize/Competition, By , With Comments Off on Innovation wanted: Baden-Württemberg Innovation Award 2018

Also in 2018, the state of Baden-Württemberg is happy to announce the Innovation Award of the State of Baden-Württemberg (€50.000). The prize is awarded to outstanding small and medium-sized enterprises from industry, trade and technological service located in the Baden-Württemberg active in the development of new products, processes and technological…

Press Release: “Proposal Writing Training for H2020 applications“

On March 8, 2018, Posted by , In Press Releases, By , With Comments Off on Press Release: “Proposal Writing Training for H2020 applications“

Heidelberg, 08.03.2018 BioRN together with the German national contact point (Nationale Kontakstellen – NKS), organised on Wednesday, April the 7th a training for H2020 applications writing. Potential applicants with a concrete project in their pipeline were admitted to the training and could discuss technical improvements and pitfalls with the experts….

New EMBL spinoff company Velabs Therapeutics to accelerate antibody discovery

On March 8, 2018, Posted by , In News, By , , With Comments Off on New EMBL spinoff company Velabs Therapeutics to accelerate antibody discovery

An established proprietary microfluidics technology from the European Molecular Biology Laboratory (EMBL) allows for fast screening of antibodies from natural sources and even difficult targets. With the startup company Velabs Therapeutics, launched by EMBL and its technology transfer arm EMBLEM Technology Transfer GmbH (EMBLEM) together with private investors, the advantages…

EMBL recognises the outstanding work of alumni with the John Kendrew and Lennart Philipson Awards

On March 7, 2018, Posted by , In News, By , , With Comments Off on EMBL recognises the outstanding work of alumni with the John Kendrew and Lennart Philipson Awards

From Big Data to viral enzymes, EMBL alumni are tackling questions across the full range of science disciplines. This year’s alumni awards celebrate this diversity by showcasing the work of Nils Gehlenborg, winner of the 2018 John Kendrew Young Scientist Award, and Raffaele De Francesco, winner of the 2018 Lennart Philipson Award….